Regeneron Pharmaceuticals
Agent43Agent Readiness: 43/100. Above median. Measured by StartupHub.ai. Median 41.Trust68Data Trust: 68/100. Above median. Measured by StartupHub.ai. Median 61.A biotechnology company that invents, develops, manufactures, and commercializes medicines for serious diseases.
About
Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company founded in 1988, headquartered in Westchester County, New York. The company focuses on discovering and developing innovative medicines for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases.
Similar companies
Biotech company developing novel therapeutics for regenerative medicine and oncology.
Shares Biotech, MedTech
A clinical-stage biopharmaceutical company developing novel immunotherapies.
Shares Pharmaceuticals, Biotech
Developing transformative fusion immunotherapeutics for autoimmune diseases, cancer, and senescence-associated dysplasia.
Shares Biotech, Drug Discovery
Leveraging the adaptive immune system to diagnose and treat disease.
Shares Biotech, Drug Discovery
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, MedTech
Developing engineered biologics to harness the immune system for disease treatment.
Shares Biotech, Drug Discovery
Key facts
- Website
- regeneron.com
- Headquarters
- Westchester County, New York, United States
- Founded
- 1988
- Business model
- B2B
Tech stack
Detected on regeneron.com, last scanned 21 Sept 2026. Run your own scan
- Frontend
- Bootstrap
- Auth
- Okta
- Analytics
- Google Tag Manager
- CDN
- Cloudflare
- Email provider
- Proofpoint
- Cookie consent
- OneTrust
- Hiring platform
- Happydance
- Video / media
- Vimeo
Regeneron Pharmaceuticals scores 79. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
What does Regeneron Pharmaceuticals do?
With 13 medicines approved and nearly 100% of products invented in-house, Regeneron serves patients in over 100 countries. The company invested $4.4 billion into R&D in 2023 with 30+ programs in clinical development.
Is Regeneron Pharmaceuticals trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Regeneron Pharmaceuticals is 68 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Regeneron Pharmaceuticals
